Hematology TimesCombo targets AML, BL in the same wayMay 17, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLNon-Hodgkin Lymphoma
Hematology TimesFDA grants drug orphan designation for AMLMay 15, 2015Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesGroup learns how protein promotes AMLMay 15, 2015Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesModified T cells may treat GVHDMay 14, 2015AnemiaLeukemia, Myelodysplasia, TransplantationTransplantation
The Journal of Community and Supportive OncologyBlinatumomab for hard-to-treat form of acute lymphoblastic leukemiaMay 13, 2015Leukemia, Myelodysplasia, Transplantation
The Journal of Community and Supportive OncologyThe generalist’s dilemma: training and staying current in the face of increasing specializationMay 13, 2015Leukemia, Myelodysplasia, TransplantationPatient & Survivor Care
Hematology NewsElotuzumab plus len-dex extends remissions of multiple myelomaMay 13, 2015Multiple MyelomaLeukemia, Myelodysplasia, Transplantation
Hematology TimesFamilial factors linked to child’s risk of blood cancerMay 13, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple Myeloma
Hematology TimesTeam links telomere degeneration and MDSMay 12, 2015AnemiaLeukemia, Myelodysplasia, TransplantationMyelodysplastic Syndrome
Hematology TimesExplaining obesity in cancer survivorsMay 11, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPediatricsRelated Issues
Hematology TimesInhibitor may benefit certain ALL patientsMay 9, 2015Leukemia, Myelodysplasia, TransplantationPediatricsALL
Hematology TimesProtein linked to leukemia, breast cancerMay 8, 2015Leukemia, Myelodysplasia, Transplantation
Hematology TimesTool identifies CNAs other algorithms missMay 7, 2015Leukemia, Myelodysplasia, TransplantationPediatricsRelated Issues
Hematology TimesInhibitor gets breakthrough designation for CLLMay 7, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesAgent preferentially targets FLT3-ITD AMLMay 7, 2015Leukemia, Myelodysplasia, TransplantationAML
